This will be a multicenter, randomized, double-blind, placebo-controlled, study to evaluate the safety and efficacy of LB1148 in return to bowel function for subjects undergoing planned bowel resection.
The purpose of this study is to evaluate the safety and efficacy of LB1148 in subjects undergoing planned bowel resection.